Pharmacokinetic Study of DA-020 (NCT07402330) | Clinical Trial Compass
Not Yet RecruitingEarly Phase 1
Pharmacokinetic Study of DA-020
Brazil, Italy60 participantsStarted 2026-04-16
Plain-language summary
Pharmacokinetic Study of DA-020
Who can participate
Age range18 Years – 55 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Healthy females, age 18-55
* BMI: 18-30 kg/m²
* Fitzpatrick Skin Types I-IV (to standardize absorption risk)
* Scalp free from irritation, dermatologic disease, or damage
* Able to refrain from using other topical scalp products
Exclusion Criteria:
* History of cardiovascular disease, hypertension, or arrhythmia
* Scalp infections, wounds, or significant hair loss
* Recent use of medications that interfere with CYP enzymes or adrenergic systems
* Known sensitivity to phenylephrine or ethanol
* Positive drug screen or abnormal ECG at screening